Cargando…

Long-term virologic and immunologic responses on darunavir/ritonavir – containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in São Paulo, Brazil

Detalles Bibliográficos
Autores principales: Vidal, José E., Santos, Ariane M.R. dos, Peixoto de Miranda, Érique J.F., Segurado, Aluísio C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425474/
https://www.ncbi.nlm.nih.gov/pubmed/28964777
http://dx.doi.org/10.1016/j.bjid.2017.07.005
_version_ 1784778457653182464
author Vidal, José E.
Santos, Ariane M.R. dos
Peixoto de Miranda, Érique J.F.
Segurado, Aluísio C.
author_facet Vidal, José E.
Santos, Ariane M.R. dos
Peixoto de Miranda, Érique J.F.
Segurado, Aluísio C.
author_sort Vidal, José E.
collection PubMed
description
format Online
Article
Text
id pubmed-9425474
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94254742022-08-31 Long-term virologic and immunologic responses on darunavir/ritonavir – containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in São Paulo, Brazil Vidal, José E. Santos, Ariane M.R. dos Peixoto de Miranda, Érique J.F. Segurado, Aluísio C. Braz J Infect Dis Letter to the Editor Elsevier 2017-09-29 /pmc/articles/PMC9425474/ /pubmed/28964777 http://dx.doi.org/10.1016/j.bjid.2017.07.005 Text en © 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Vidal, José E.
Santos, Ariane M.R. dos
Peixoto de Miranda, Érique J.F.
Segurado, Aluísio C.
Long-term virologic and immunologic responses on darunavir/ritonavir – containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in São Paulo, Brazil
title Long-term virologic and immunologic responses on darunavir/ritonavir – containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in São Paulo, Brazil
title_full Long-term virologic and immunologic responses on darunavir/ritonavir – containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in São Paulo, Brazil
title_fullStr Long-term virologic and immunologic responses on darunavir/ritonavir – containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in São Paulo, Brazil
title_full_unstemmed Long-term virologic and immunologic responses on darunavir/ritonavir – containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in São Paulo, Brazil
title_short Long-term virologic and immunologic responses on darunavir/ritonavir – containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in São Paulo, Brazil
title_sort long-term virologic and immunologic responses on darunavir/ritonavir – containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in são paulo, brazil
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425474/
https://www.ncbi.nlm.nih.gov/pubmed/28964777
http://dx.doi.org/10.1016/j.bjid.2017.07.005
work_keys_str_mv AT vidaljosee longtermvirologicandimmunologicresponsesondarunavirritonavircontainingregimensamonghighlyantiretroviraltherapyexperiencedpatients7yearfollowupofaprospectivecohortstudyinsaopaulobrazil
AT santosarianemrdos longtermvirologicandimmunologicresponsesondarunavirritonavircontainingregimensamonghighlyantiretroviraltherapyexperiencedpatients7yearfollowupofaprospectivecohortstudyinsaopaulobrazil
AT peixotodemirandaeriquejf longtermvirologicandimmunologicresponsesondarunavirritonavircontainingregimensamonghighlyantiretroviraltherapyexperiencedpatients7yearfollowupofaprospectivecohortstudyinsaopaulobrazil
AT seguradoaluisioc longtermvirologicandimmunologicresponsesondarunavirritonavircontainingregimensamonghighlyantiretroviraltherapyexperiencedpatients7yearfollowupofaprospectivecohortstudyinsaopaulobrazil